NOSOPHARM has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2009. It filed its patents most often in WIPO (World Intellectual Property Organization), EPO (European Patent Office) and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are LABORATORIOS SILANES S A DE C V, GENSPERA INC and CUTHBERTSON ALAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | France | 2 | |
#6 | United States | 2 | |
#7 | Australia | 1 | |
#8 | Brazil | 1 | |
#9 | Israel | 1 | |
#10 | India | 1 | |
#11 | Republic of Korea | 1 | |
#12 | Mexico | 1 | |
#13 | Russian Federation | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Fermentation | |
#5 | Microorganisms | |
#6 | Acyclic or carbocyclic compounds | |
#7 | Heterocyclic compounds | |
#8 | Microorganisms | |
#9 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Gualtieri Maxime | 14 |
#2 | Villain-Guillot Philippe | 13 |
#3 | Racine Emilie | 11 |
#4 | Givaudan Alain | 7 |
#5 | Pages Sylvie | 7 |
#6 | Villain Guillot Philippe | 3 |
#7 | Philippe Villain-Guillot | 3 |
#8 | Emilie Racine | 3 |
#9 | Maxime Gualtieri | 3 |
#10 | Vijen-Gillo Filipp | 1 |
Publication | Filing date | Title |
---|---|---|
CN106715460A | Novel peptide derivatives and uses thereof | |
WO2015128504A1 | Process for preparing 2,4-diamino-3-hydroxybutyric acid derivatives | |
EP2760881A1 | Novel peptide derivatives as antibiotics | |
WO2012085177A1 | Nemaucin, an antibiotic produced by entomopathogenic xenorhabdus cabanillasii | |
EP2468718A1 | Cabanillasin, a new antifungal compound, produced by entomopathogenic xenorhabdus cabanillasii | |
FR2946058A1 | Process for increasing the diversity of secondary metabolites of interest produced by microorganisms |